Turn Therapeutics Ownership | Who Owns Turn Therapeutics?


OverviewFinancialsChart

Turn Therapeutics Ownership Summary


Turn Therapeutics is owned by 3.36% institutional investors, 63.74% insiders, and 32.90% retail investors. Ddfg is the largest institutional shareholder, holding 0.51% of TTRX shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 0.13% of its assets in Turn Therapeutics shares.

TTRX Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockTurn Therapeutics3.36%63.74%32.90%
SectorHealthcare Stocks 35.75%11.89%52.37%
IndustryBiotech Stocks 36.05%11.82%52.13%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Ddfg70.53K0.51%$225.71K
Millennium management69.76K0.51%$223.22K
Wellington shields65.73K0.48%$210.34K
Tamar securities30.00K0.22%$96.00K
Brown brothers harriman23.69K0.17%$75.80K
Xtx topco19.73K0.14%$63.13K
Hightower advisors19.68K0.14%$62.99K
Rvw wealth18.00K0.13%$57.60K
Geode capital management17.14K0.12%$54.85K
Miracle mile advisors16.00K0.12%$51.20K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Wellington shields65.73K0.05%$210.34K
Ddfg70.53K0.05%$225.71K
Tamar securities30.00K0.01%$96.00K
Rvw wealth18.00K0.00%$57.60K
Hodges capital management10.00K0.00%$32.00K
Xtx topco19.73K0.00%$63.13K
Miracle mile advisors16.00K0.00%$51.20K
Brown brothers harriman23.69K0.00%$75.80K
Pflug koory170.000.00%$544.00
Millennium management69.76K0.00%$223.22K

Top Buyers

HolderShares% AssetsChange
Ddfg70.53K0.05%18.25K
Tamar securities30.00K0.01%15.00K
Vanguard fiduciary trust12.48K-12.48K
Ubs group400.00-400.00
Lpl financial13.30K-300.00

Top Sellers

HolderShares% AssetsChange
Millennium management69.76K0.00%-25.87K
Citadel advisors---20.99K
Jane street group---17.17K
Xtx topco19.73K0.00%-5.45K
Royal bank of canada---267.00

New Positions

HolderShares% AssetsChangeValue
Vanguard fiduciary trust12.48K-12.48K$39.94K
Ubs group400.00-400.00$1.28K

Sold Out

HolderChange
Tower research capital llc (trc)-137.00
Royal bank of canada-267.00
Jane street group-17.17K
Citadel advisors-20.99K

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 202620-9.09%462,310-0.89%329.20%6-72.73%2-
Dec 31, 202522-466,461-3-22---

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv39.57K0.13%5.70K
Fidelity Nasdaq Composite Index17.14K0.06%-
Vanguard Balanced Index Inv15.58K0.05%-
Vanguard Instl Ttl Stck Mkt Index Trust12.48K0.04%-
JHVIT Total Stock Market Index I640.000.00%-

TTRX Ownership FAQ


Who Owns Turn Therapeutics?

Turn Therapeutics shareholders are primarily institutional investors at 3.36%, followed by 63.74% insiders and 32.90% retail investors. The average institutional ownership in Turn Therapeutics's industry, Biotech Stocks , is 36.05%, which Turn Therapeutics falls below.

Who owns the most shares of Turn Therapeutics?

Turn Therapeutics’s largest shareholders are Ddfg (70.53K shares, 0.51%), Millennium management (69.76K shares, 0.51%), and Wellington shields (65.73K shares, 0.48%). Together, they hold 1.50% of Turn Therapeutics’s total shares outstanding.

Does Blackrock own Turn Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Turn Therapeutics.

Who is Turn Therapeutics’s biggest shareholder by percentage of total assets invested?

Wellington shields is Turn Therapeutics’s biggest shareholder by percentage of total assets invested, with 0.05% of its assets in 65.73K Turn Therapeutics shares, valued at 210.34K$.

Who is the top mutual fund holder of Turn Therapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Turn Therapeutics shares, with 0.13% of its total shares outstanding invested in 39.57K Turn Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools